Invention Grant
- Patent Title: Cyclodecapeptide compounds for use as drugs
-
Application No.: US13698450Application Date: 2011-05-17
-
Publication No.: US09856294B2Publication Date: 2018-01-02
- Inventor: Pascale Delangle , Anaïs Pujol , Pascal Dumy , Olivier Renaudet , Michel Ferrand
- Applicant: Pascale Delangle , Anaïs Pujol , Pascal Dumy , Olivier Renaudet , Michel Ferrand
- Applicant Address: FR Paris FR Grenoble
- Assignee: Commissariat A L'Energie Atomique Et Aux Energies Alternatives,Universite Joseph Fourier
- Current Assignee: Commissariat A L'Energie Atomique Et Aux Energies Alternatives,Universite Joseph Fourier
- Current Assignee Address: FR Paris FR Grenoble
- Agency: Alston & Bird LLP
- Priority: FR1002062 20100517
- International Application: PCT/IB2011/052162 WO 20110517
- International Announcement: WO2011/145055 WO 20111124
- Main IPC: C07K9/00
- IPC: C07K9/00 ; C07K7/64 ; A61K49/00
Abstract:
The invention relates to novel cyclodecapeptide compounds having formula (I) for use as drugs and, more specifically, for use in the diagnosis, prevention and/or treatment of neurodegenerative diseases, such as Wilson's disease and Alzheimer's disease, and for use in the diagnosis, prevention and/or treatment of poisoning with metal ions, such as copper and mercury ions. The invention also relates to pharmaceutical compositions comprising at least one compound having formula (I) as an active principle.
Public/Granted literature
- US20130251639A1 Novel Cyclodecapeptide Compounds For Use As Drugs Public/Granted day:2013-09-26
Information query
